These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 31664964)

  • 21. Cannabis-Responsive Biomarkers: A Pharmacometabolomics-Based Application to Evaluate the Impact of Medical Cannabis Treatment on Children with Autism Spectrum Disorder.
    Siani-Rose M; Cox S; Goldstein B; Abrams D; Taylor M; Kurek I
    Cannabis Cannabinoid Res; 2023 Feb; 8(1):126-137. PubMed ID: 34874191
    [No Abstract]   [Full Text] [Related]  

  • 22. Medicinal Cannabis for Paediatric Developmental, Behavioural and Mental Health Disorders.
    Efron D; Taylor K
    Int J Environ Res Public Health; 2023 Apr; 20(8):. PubMed ID: 37107712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological management of behavioral disturbances in children and adolescents with autism spectrum disorders.
    Lamy M; Erickson CA
    Curr Probl Pediatr Adolesc Health Care; 2018 Oct; 48(10):250-264. PubMed ID: 30262163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychopharmacological interventions in autism spectrum disorder.
    Accordino RE; Kidd C; Politte LC; Henry CA; McDougle CJ
    Expert Opin Pharmacother; 2016; 17(7):937-52. PubMed ID: 26891879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brief Report: Suspected Cannabis-Induced Mania and Psychosis in Young Adult Males with Autism Spectrum Disorder.
    Al-Soleiti M; Balaj K; Thom RP; McDougle CJ; Keary CJ
    J Autism Dev Disord; 2022 Sep; 52(9):4164-4171. PubMed ID: 34505186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effectiveness and adverse effects of D-cycloserine compared with placebo on social and communication skills in individuals with autism spectrum disorder.
    Aye SZ; Ni H; Sein HH; Mon ST; Zheng Q; Wong YKY
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013457. PubMed ID: 33583058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Symptoms, adverse events, and outcomes in the use of medicinal cannabis in children and adolescents with autism spectrum disorder: a scoping review protocol.
    Fletcher S; Pawliuk C; Ip A; Oberlander T; Siden H
    JBI Evid Synth; 2021 May; 19(5):1251-1258. PubMed ID: 33165173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cannabidiol for the treatment of autism spectrum disorder: hope or hype?
    Pedrazzi JFC; Ferreira FR; Silva-Amaral D; Lima DA; Hallak JEC; Zuardi AW; Del-Bel EA; Guimarães FS; Costa KCM; Campos AC; Crippa ACS; Crippa JAS
    Psychopharmacology (Berl); 2022 Sep; 239(9):2713-2734. PubMed ID: 35904579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Behavioural and cognitive behavioural therapy for obsessive compulsive disorder (OCD) in individuals with autism spectrum disorder (ASD).
    Elliott SJ; Marshall D; Morley K; Uphoff E; Kumar M; Meader N
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD013173. PubMed ID: 34693989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implications of the endocannabinoid system and the therapeutic action of cannabinoids in autism spectrum disorder: A literature review.
    de Camargo RW; de Novais Júnior LR; da Silva LM; Meneguzzo V; Daros GC; da Silva MG; de Bitencourt RM
    Pharmacol Biochem Behav; 2022 Nov; 221():173492. PubMed ID: 36379443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autism Spectrum Disorder: Classification, diagnosis and therapy.
    Sharma SR; Gonda X; Tarazi FI
    Pharmacol Ther; 2018 Oct; 190():91-104. PubMed ID: 29763648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interventions for improving employment outcomes for persons with autism spectrum disorders: A systematic review update.
    Fong CJ; Taylor J; Berdyyeva A; McClelland AM; Murphy KM; Westbrook JD
    Campbell Syst Rev; 2021 Sep; 17(3):e1185. PubMed ID: 37052419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CBD-enriched cannabis for autism spectrum disorder: an experience of a single center in Turkey and reviews of the literature.
    Bilge S; Ekici B
    J Cannabis Res; 2021 Dec; 3(1):53. PubMed ID: 34911567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the efficacy and safety of cannabidiol-rich cannabis extract in children with autism spectrum disorder: randomized, double-blind, and placebo-controlled clinical trial.
    Silva EAD; Medeiros WMB; Santos JPMD; Sousa JMM; Costa FBD; Pontes KM; Borges TC; Espínola C; Andrade E Silva AH; Nunes ELG; Alves NT; Rosa MDD; Albuquerque KLGD
    Trends Psychiatry Psychother; 2024; 46():e20210396. PubMed ID: 35617670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autism and associated disorders: cannabis as a potential therapy.
    Babayeva M; Assefa H; Basu P; Loewy Z
    Front Biosci (Elite Ed); 2022 Jan; 14(1):1. PubMed ID: 35320905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Millennium Nutrient N,N-Dimethylglycine (DMG) and its Effectiveness in Autism Spectrum Disorders.
    Dhanjal DS; Bhardwaj S; Chopra C; Singh R; Patocka J; Plucar B; Nepovimova E; Valis M; Kuca K
    Curr Med Chem; 2022; 29(15):2632-2651. PubMed ID: 34823458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabinoids for Treatment of MS Symptoms: State of the Evidence.
    Rice J; Cameron M
    Curr Neurol Neurosci Rep; 2018 Jun; 18(8):50. PubMed ID: 29923025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autism Spectrum Disorder and Complementary-Integrative Medicine.
    Vandana P; Simkin DR; Hendren RL; Arnold LE
    Child Adolesc Psychiatr Clin N Am; 2023 Apr; 32(2):469-494. PubMed ID: 37147047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.